VYGR logo

Voyager Therapeutics (VYGR) Company Overview

Profile

Full Name:

Voyager Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 11, 2015

Indexes:

Not included

Description:

Voyager Therapeutics is a biotechnology company focused on developing gene therapies for neurological diseases. They aim to create innovative treatments using their advanced delivery systems to target the brain and central nervous system, helping patients with conditions like Parkinson's disease and other serious disorders.

Key Details

Price

$4.20

Annual Revenue

$250.01 M(+511.16% YoY)

Annual EPS

$2.97(+345.45% YoY)

Beta

1.64

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 3, 25 HC Wainwright & Co.
Buy
Jan 27, 25 HC Wainwright & Co.
Buy
Jan 10, 25 Cantor Fitzgerald
Overweight
Dec 2, 24 Citigroup
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Canaccord Genuity
Buy
Oct 24, 24 HC Wainwright & Co.
Buy
Oct 16, 24 Leerink Partners
Outperform
Aug 20, 24 HC Wainwright & Co.
Buy
Aug 7, 24 Wedbush
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Voyager Therapeutics?
  • Does Voyager Therapeutics pay dividends?
  • What sector is Voyager Therapeutics in?
  • What industry is Voyager Therapeutics in?
  • What country is Voyager Therapeutics based in?
  • When did Voyager Therapeutics go public?
  • Is Voyager Therapeutics in the S&P 500?
  • Is Voyager Therapeutics in the NASDAQ 100?
  • Is Voyager Therapeutics in the Dow Jones?
  • When was Voyager Therapeutics's last earnings report?
  • When does Voyager Therapeutics report earnings?
  • Should I buy Voyager Therapeutics stock now?

What is the ticker symbol for Voyager Therapeutics?

The ticker symbol for Voyager Therapeutics is NASDAQ:VYGR

Does Voyager Therapeutics pay dividends?

No, Voyager Therapeutics does not pay dividends

What sector is Voyager Therapeutics in?

Voyager Therapeutics is in the Healthcare sector

What industry is Voyager Therapeutics in?

Voyager Therapeutics is in the Biotechnology industry

What country is Voyager Therapeutics based in?

Voyager Therapeutics is headquartered in United States

When did Voyager Therapeutics go public?

Voyager Therapeutics's initial public offering (IPO) was on November 11, 2015

Is Voyager Therapeutics in the S&P 500?

No, Voyager Therapeutics is not included in the S&P 500 index

Is Voyager Therapeutics in the NASDAQ 100?

No, Voyager Therapeutics is not included in the NASDAQ 100 index

Is Voyager Therapeutics in the Dow Jones?

No, Voyager Therapeutics is not included in the Dow Jones index

When was Voyager Therapeutics's last earnings report?

Voyager Therapeutics's most recent earnings report was on Feb 28, 2025

When does Voyager Therapeutics report earnings?

The date for Voyager Therapeutics's next earnings report has not been announced yet

Should I buy Voyager Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions